In vitro dissolution/release methods for mucosal delivery systems

In vitro dissolution/release tests are an indispensable tool in the drug product development, its quality control and the regulatory approval process. Mucosal drug delivery systems are designed to provide both local and systemic drug action following ocular, nasal, oromucosal, vaginal or rectal admi...

Full description

Saved in:
Bibliographic Details
Main Authors: Mario Jug (Author), Anita Hafner (Author), Jasmina Lovrić (Author), Maja Lusina Kregar (Author), Ivan Pepić (Author), Željka Vanić (Author), Biserka Cetina-Čižmek (Author), Jelena Filipović-Grčić (Author)
Format: Book
Published: International Association of Physical Chemists (IAPC), 2017-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c99e6ed6ea464c3598babb1a1ae55e0a
042 |a dc 
100 1 0 |a Mario Jug  |e author 
700 1 0 |a Anita Hafner  |e author 
700 1 0 |a Jasmina Lovrić  |e author 
700 1 0 |a Maja Lusina Kregar  |e author 
700 1 0 |a Ivan Pepić  |e author 
700 1 0 |a Željka Vanić  |e author 
700 1 0 |a Biserka Cetina-Čižmek  |e author 
700 1 0 |a Jelena Filipović-Grčić  |e author 
245 0 0 |a In vitro dissolution/release methods for mucosal delivery systems 
260 |b International Association of Physical Chemists (IAPC),   |c 2017-09-01T00:00:00Z. 
500 |a 1848-7718 
500 |a 10.5599/admet.5.3.425 
520 |a In vitro dissolution/release tests are an indispensable tool in the drug product development, its quality control and the regulatory approval process. Mucosal drug delivery systems are designed to provide both local and systemic drug action following ocular, nasal, oromucosal, vaginal or rectal administration. They exhibit significant differences in formulation design, physicochemical characteristics and drug release properties. Therefore it is not possible to devise a single method which would be suitable for release testing of such versatile and complex dosage forms. Different apparatuses and techniques for in vitro release testing for mucosal delivery systems considering the specific conditions at the administration site are described. In general, compendial apparatuses and methods should be used as a first approach in method development when applicable. However, to assure adequate simulation of conditions in vivo, novel biorelevant in vitro dissolution/release methods should be developed. Equipment set up, the selection of dissolution media and volume, membrane type, agitation speed, temperature, and assay analysis technique need to be carefully defined based on mucosal drug delivery system characteristics. All those parameters depend on the delivery system and physiological conditions at the site of application and may vary in a wide range, which will be discussed in details. 
546 |a EN 
690 |a In vitro dissolution/release test 
690 |a nasal drug delivery 
690 |a ocular drug delivery 
690 |a oromucosal drug delivery 
690 |a rectal drug delivery 
690 |a vaginal drug delivery 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n ADMET and DMPK, Vol 5, Iss 3, Pp 173-182 (2017) 
787 0 |n http://pub.iapchem.org/ojs/index.php/admet/article/view/425 
787 0 |n https://doaj.org/toc/1848-7718 
856 4 1 |u https://doaj.org/article/c99e6ed6ea464c3598babb1a1ae55e0a  |z Connect to this object online.